NICOX PREPARE SON COUP AVEC LA NOTICE
ENCORE DES POINTURES EN SOUTIEND
LE 21 AVRIL
Innovative Approaches for a New Generation of Therapeutic Options for the Management of Osteoarthritis Patients
Supported by NicOx, Inc.
Metro Toronto Convention Centre
organisé par :innovation consulting group LLC
REGARDER QUI EST PARTNERSCHIPS
SDG,LLC Regulatory Expertise and Strategic Planning for FDA -Regulated Industry
Welcome to the website of SDG, LLC, advisors to the management and Boards of FDA-regulated industry.
COMME SDG ?le docteur LEE SIMON AFFILIATION AND/OR FINANCIAL INTERESTS COMPANY /AVEC NICOX ENTRE AUTRE
DR. LEE SIMON– a physician and research scientist who has served as the FDA’s Division Director of Analgesic, Anti-inflammatory and Ophthalmologic Drug Products, as well as a consultant to multiple FDA advisory committees and has extensive experience in drug development